CGTX (STOCKS)
Cognition Therapeutics, Inc. Common Stock
$1.225200
+0.015200 (+1.26%)
Prev close: $1.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Lisa R. Ricciardi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $108.74M
- Employees
- 25
- P/E (TTM)
- -4.69
- P/B (TTM)
- 3.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.05 | $-0.07 | +0.0189 | +27.43% |
|
Dec 2025 (Q4)
|
$-0.05 | $-0.09 | +0.0370 | +43.53% |
|
Sep 2025 (Q3)
|
$-0.06 | $-0.10 | +0.0420 | +41.18% |
|
Jun 2025 (Q2)
|
$-0.11 | $-0.11 | -0.0012 | -1.10% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $42.84M |
| Research and Development | $32.52M |
| Other Operating Expenses | $10.32M |
| Operating Income/Loss | -$42.84M |
| Income/Loss From Continuing Operations After Tax | -$19.58M |
| Income/Loss From Continuing Operations Before Tax | -$19.58M |
| Net Income/Loss | -$19.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.24 |
| Diluted Earnings Per Share | -$0.24 |
| Basic Average Shares | 236,112,609 |
| Diluted Average Shares | 236,112,609 |
| Assets | $36.14M |
| Current Assets | $35.81M |
| Prepaid Expenses | $932.00K |
| Other Current Assets | $34.88M |
| Noncurrent Assets | $326.00K |
| Fixed Assets | $77.00K |
| Other Non-current Assets | $249.00K |
| Liabilities | $6.23M |
| Current Liabilities | $6.05M |
| Accounts Payable | $3.85M |
| Wages | $498.00K |
| Other Current Liabilities | $1.71M |
| Noncurrent Liabilities | $176.00K |
| Equity | $29.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.91M |
| Liabilities And Equity | $36.14M |
| Net Cash Flow From Operating Activities | -$20.25M |
| Net Cash Flow From Operating Activities, Continuing | -$20.25M |
| Net Cash Flow From Investing Activities | -$2.80M |
| Net Cash Flow From Investing Activities, Continuing | -$2.80M |
| Net Cash Flow From Financing Activities | $35.04M |
| Net Cash Flow From Financing Activities, Continuing | $35.04M |
| Net Cash Flow | $11.99M |
| Net Cash Flow, Continuing | $11.99M |
| Comprehensive Income/Loss | -$19.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.58M |
| Other Comprehensive Income/Loss | $10.64M |